Morgan Stanley’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Morgan Stanley’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,171,195	Closed	-$631M	–	6950
2014 Q4	$631M	Sell	6,171,195 -319,705	-5%	-$30.7M	0.23%	90
2014 Q3	$562M	Buy	6,490,900 +705,567	+12%	+$62.5M	0.22%	94
2014 Q2	$522M	Buy	5,785,333 +2,131,155	+58%	+$159M	0.2%	100
2014 Q1	$269M	Buy	3,654,178 +72,161	+2%	+$5.03M	0.11%	212
2013 Q4	$244M	Buy	3,582,017 +387,960	+12%	+$25.2M	0.1%	218
2013 Q3	$195M	Sell	3,194,057 -544,813	-15%	-$33.2M	0.09%	241
2013 Q2	$208M	Buy	+3,738,870	New	+$216M	0.11%	227

Morgan Stanley's COV Position: Q1 2015 in Review

Morgan Stanley sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 6,171,195 shares — an estimated $631M sold.

Morgan Stanley first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $631M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Morgan Stanley reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Morgan Stanley sold 6,171,195 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $631M.
Morgan Stanley first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
Morgan Stanley's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $631M in Q4 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Morgan Stanley's 13F filing for Q1 2015, filed 14 May 2015.